Severe mesenteric ischemia with multiple organ failure in a patient previously treated with a humanized monoclonal antibody against programmed death receptor-1 (pembrolizumab), a c...

por Mintjens-Jager, E M W, Vos, M E, Kats-Ugurlu, G, Hospers, G A P, Rutgers, A, van Meurs, M
Publicado 2020

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy

por Hulshoff, J. B., Faiz, Z., Karrenbeld, A., Kats-Ugurlu, G., Burgerhof, J. G. M., Smit, J. K., Plukker, J. Th. M.
Publicado 2015

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy...

por Wang, H. H., Steffens, E. N., Kats-Ugurlu, G., van Etten, B., Burgerhof, J. G. M., Hospers, G. A. P., Plukker, J. T. M.
Publicado 2023

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer

por Wang, H. H., Steffens, E. N., Kats-Ugurlu, G., van Etten, B., Burgerhof, J. G. M., Hospers, G. A. P., Plukker, J. T. M.
Publicado 2023

Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett’s esophagus biopsies – towards digital review of Barrett’s esophagus

por van der Wel, MJ, Klaver, E, Duits, LC, Pouw, RE, Seldenrijk, CA, Offerhaus, GJA, Visser, M, ten Kate, FJW, Biermann, K, Brosens, LAA, Doukas, M, Huysentruyt, C, Karrenbeld, A, Kats-Ugurlu, G, van der Laan, JS, van Lijnschoten, G, Moll, FCP, Ooms, AHAG, Tijssen, JG, Bergman, JJGHM, Meijer, SL
Publicado 2019